Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Medtech Ventures | Femoro-Popliteal Angioplasty and Stenting

Femoro-Popliteal Angioplasty and Stenting

The market for Fem-Pop Angioplasty & Stenting has experienced explosive growth recently mainly due to the launch and acceptance of novel atherectomy devices like the SilverHawk, and the regulatory approval of dedicated Stents.

At the end of 2005 the market was estimated at $470 million, growing by 30% over the previous year.

Peripheral Arterial Disease (PAD) of the Femoro-popliteal System is a major cause of morbidity and limb loss accounting for over 300,000 amputations in the developed world every year.

Medical therapy is often ineffective and open surgery has substantial risks. Less invasive endovascular approaches has been utilized for several decades in the Femoropopliteal System however, a major limiting factor was late restenosis.

Recent breakthroughs in stent material and design and the introduction of dedicated flexible stents with high radial force that can deliver superior outcome to open surgery promise to rewrite protocols of care and revolutionize the market for Lower Limb Endovascular Revascularization and Repair.

Medtech Ventures' Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast report gives an overview of the state of both the technology and the market. It profiles the current market landscape and explores the market potential with global forecasts to 2010.

The report draws on the latest findings presented at EuroPCR conference and details many pressing issues in the Fem-Pop Angioplasty & Stenting space including current approved and in-development devices and the status of clinical development of potential new entrants.

Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast is your exclusive introduction to top companies and their forward-thinking technologies.

Report Highlights:

1. Current state of the science of superficial femoral artery (SFA) angioplasty & stenting.

2. Recent clinical trials and their findings. Epidemiology of PAD, CLI and estimated number of endovascular procedures.

3. Current market for fem-pop angioplasty & stenting segmented geographically.

4. Potential market for fem-pop angioplasty, stenting, brachytherapy, laser therapy and plaque excision.

5. Leading players in the fem-pop angioplasty and stenting space and potential entrants.

6. Market forecasts to 2010.

Femoro-Popliteal Angioplasty & Stenting - Technology & Market Forecast gives a short but thorough analysis of the global potential market for superficial femoral artery (SFA) endovascular repair.

The report is targeted at busy medtech executives & venture capitalists scanning for windows of opportunities opening in the peripheral endovascular space.

Published: Sep 2006

Pages: 28

PDF Format
Table of Contents
Price: $1,040.00 / €695.14

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions